Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Daniel O'Day
Special Reports
The top 10 best-paid CEOs in Big Pharma in 2023
One surefire sign things are starting to balance out when it comes to C-suite compensation? The fact that a Johnson & Johnson helmsman has once again topped the list.
Fraiser Kansteiner
,
Eric Sagonowsky
,
Angus Liu
,
Kevin Dunleavy
,
Zoey Becker
Jun 17, 2024 3:00am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M
Mar 19, 2024 1:13pm
PhRMA taps Gilead CEO Dan O'Day as its new board chair
Feb 21, 2024 2:51pm
Struggling Biogen paid its 2 CEOs more than $57M last year
May 1, 2023 10:47am
Gilead handed its CEO Daniel O'Day a healthy pay bump in 2022
Mar 24, 2023 9:55am
